IgG4-related Ophthalmic Disease in Idiopathic Sclerosing and Non-Sclerosing Orbital Inflammation: A 25-Year Experience

References

• Yuen SJA, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121(4):491–99. doi:10.1001/archopht.121.4.491.
   PubMedGoogle Scholar
• Swamy BN, McCluskey P, Nemet A, Crouch R, Martin P, Benger R, Ghabriel R, Wakefield D. Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol. 2007;91(12):1667–70. doi:10.1136/bjo.2007.124156.
   PubMed Web of Science ®Google Scholar
• Chen Y-M, Hu F-R, Liao S-L. Idiopathic sclerosing orbital inflammation–a case series study. Ophthalmologica. 2009;224:55–58. doi:10.1159/000235564.
   PubMed Web of Science ®Google Scholar
• Sa H-S, Lee J-H, Woo KI, Kim Y-D. IgG4-related disease in idiopathic sclerosing orbital inflammation. Br J Ophthalmol. 2015;99(11):1493–97. doi:10.1136/bjophthalmol-2014-305528.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Yamamoto M, Naishiro Y, Sudoh G, Ishigami K, Yajima H, Tabeya T, Matsui M, Suzuki C, Takahashi H, et al. Necessity of early intervention for IgG4-related disease—delayed treatment induces fibrosis progression. Rheumatology. 2013;52(4):679–83. doi:10.1093/rheumatology/kes358.
   PubMed Web of Science ®Google Scholar
• Lindfield D, Attfield K, McElvanney A. Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing ‘idiopathic’from the nomenclature&quest. Eye. 2012;26:623–29. doi:10.1038/eye.2012.4.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. The Lancet. 2015;385:1460–71. doi:10.1016/S0140-6736(14)60720-0.
   PubMed Web of Science ®Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51. doi:10.1056/NEJMra1104650.
   PubMed Web of Science ®Google Scholar
• Goto H, Takahira M, Azumi A. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59(1):1–7. doi:10.1007/s10384-014-0352-2.
   PubMed Web of Science ®Google Scholar
• Andrew NH, Sladden N, Kearney DJ, Selva D. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD. Br J Ophthalmol. 2015;99:376–81. doi:10.1136/bjophthalmol-2014-305545.
   PubMed Web of Science ®Google Scholar
• Sohn EJ, Ahn HB, Roh MS, Jung WJ, Ryu WY, Kwon YH. Immunoglobulin G4 (IgG4)-positive ocular adnexal mucosa-associated lymphoid tissue lymphoma and idiopathic orbital inflammation. Adv Ophthalmic Plast Reconstr Surg. 2018;34(4):313–19. doi:10.1097/IOP.0000000000000965.
   Google Scholar
• Plaza JA, Garrity JA, Dogan A, Ananthamurthy A, Witzig TE, Salomao DR. Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease. Arch Ophthalmol. 2011;129(4):421–28. doi:10.1001/archophthalmol.2011.16.
   PubMedGoogle Scholar
• Andrew N, Kearney D, Selva D. IgG4‐related orbital disease: a meta‐analysis and review. Acta Ophthalmol (Copenh). 2013;91:694–700. doi:10.1111/j.1755-3768.2012.02526.x.
   PubMed Web of Science ®Google Scholar
• Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Toshino T, Kloppel G, Heathcode JG, Khorsroshahi A, Ferry JA, et al. Consensus statement on the pathology of IgG4-related disease. Modern Pathol. 2012;25:1181–92. doi:10.1038/modpathol.2012.72.
   PubMed Web of Science ®Google Scholar
• Karamchandani JR, Younes SF, Warnke RA, Natkunam Y. IgG4-related systemic sclerosing disease of the ocular adnexa. Am J Clin Pathol. 2012;137(5):699–711. doi:10.1309/AJCPE1G8DRHXRPIH.
   PubMed Web of Science ®Google Scholar
• Kubota T, Moritani S, Katayama M, Terasaki H. Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder. Arch Ophthalmol. 2010;128(5):577–84. doi:10.1001/archophthalmol.2010.45.
   PubMedGoogle Scholar
• Takahira M, Ozawa Y, Kawano M, Zen Y, Hamaoka S, Yamada K, Sugiyama K. Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders. Int J Rheumatol. 2012:5. Article ID 635473. doi:10.1155/2012/635473.
   Google Scholar
• Hardy TG, McNab AA, Rose GE. Enlargement of the infraorbital nerve: an important sign associated with orbital reactive lymphoid hyperplasia or immunoglobulin g4–related disease. Ophthalmology. 2014;121:1297–303. doi:10.1016/j.ophtha.2013.12.028.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74:14–18. doi:10.1136/annrheumdis-2013-204907.
   PubMed Web of Science ®Google Scholar
• Wu A, Andrew NH, McNab AA, Selva D. IgG4-related ophthalmic disease: pooling of published cases and literature review. Curr Allergy Asthm R. 2015;15:1–8. doi:10.1007/s11882-015-0530-4.
   Web of Science ®Google Scholar
• Wu A, Andrew NH, McNab AA, Selva D. Bilateral IgG4-related ophthalmic disease: a strong indication for systemic imaging. Br J Ophthalmol. 2016;100:1409–11. doi:10.1136/bjophthalmol-2015-307437.
   PubMed Web of Science ®Google Scholar
• Tomiyama T, Uchida K, Matsushita M, Ikeura T, Fukui T, Takaoka M, Nishio A, Okazaki K. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol. 2011;46(5):696–704. doi:10.1007/s00535-010-0361-y.
   PubMed Web of Science ®Google Scholar
• Andrew N, Sladden N, Kearney D, Crompton J, Selva D. Sequential biopsies from immunoglobulin G4‐related orbital disease demonstrate progressive fibrosis. Clin Exp Ophthalmol. 2014;42:789–91. doi:10.1111/ceo.12316.
   PubMed Web of Science ®Google Scholar
• Disease JS, RO GoI. A prevalence study of IgG4-related ophthalmic disease in Japan. Jpn J Ophthalmol. 2013;7(6):573–79. doi:10.1007/s10384-013-0266-4.
   Google Scholar